Clinical Trial Update: Sugammadex vs Placebo to Prevent Residual Neuromuscular Block [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing sugammadex to placebo for preventing residual neuromuscular block in general surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Surgery Procedures

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Mayo Clinic | Conditions: General Surgery | Phase 4 | Status: COMPLETED | Results posted: 2022-07-14